Ibm Retirement Fund Biomarin Pharmaceutical Inc Transaction History

Ibm Retirement Fund

$72.1 Million
Q2 2022

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 20, 2022	SELL	$71.48 - $86.85 $207,292 - $251,864	-2,900 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$74.28 - $92.69 $10,399 - $12,976	-140 Reduced 4.61%	2,900 $224,000
Q4 2021 Jan 19, 2022	SELL	$71.72 - $91.47 $150,038 - $191,355	-2,092 Reduced 40.76%	3,040 $269,000
Q2 2021 Jul 12, 2021	SELL	$75.51 - $84.79 $75,963 - $85,298	-1,006 Reduced 16.39%	5,132 $428,000
Q1 2021 Apr 22, 2021	SELL	$74.73 - $90.69 $40,727 - $49,426	-545 Reduced 8.16%	6,138 $463,000
Q4 2020 Jan 25, 2021	SELL	$72.61 - $90.2 $68,035 - $84,517	-937 Reduced 12.3%	6,683 $586,000
Q3 2020 Oct 16, 2020	BUY	$71.87 - $131.03 $118,441 - $215,937	1,648 Added 27.6%	7,620 $580,000
Q2 2020 Jul 08, 2020	BUY	$79.55 - $124.22 $2,863 - $4,471	36 Added 0.61%	5,972 $737,000
Q1 2020 Apr 07, 2020	BUY	$71.37 - $96.85 $112,621 - $152,829	1,578 Added 36.21%	5,936 $502,000
Q4 2019 Jan 07, 2020	SELL	$64.27 - $86.37 $7,776 - $10,450	-121 Reduced 2.7%	4,358 $368,000
Q3 2019 Nov 06, 2019	SELL	$67.4 - $85.11 $3,167 - $4,000	-47 Reduced 1.04%	4,479 $302,000
Q2 2019 Aug 13, 2019	BUY	$80.35 - $93.9 $2,892 - $3,380	36 Added 0.8%	4,526 $388,000
Q1 2019 May 14, 2019	BUY	$84.2 - $98.62 $7,409 - $8,678	88 Added 2.0%	4,490 $399,000
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $18,352 - $24,290	-229 Reduced 4.94%	4,402 $375,000
Q3 2018 Nov 07, 2018	SELL	$93.92 - $105.72 $46,866 - $52,754	-499 Reduced 9.73%	4,631 $449,000
Q2 2018 Aug 13, 2018	SELL	$76.01 - $99.03 $35,268 - $45,949	-464 Reduced 8.29%	5,130 $483,000
Q1 2018 May 10, 2018	BUY	$77.67 - $92.63 $232,388 - $277,148	2,992 Added 114.99%	5,594 $454,000
Q3 2017 Nov 07, 2017	BUY	$80.6 - $94.95 $209,721 - $247,059	2,602	2,602 $242,000

Others Institutions Holding BMRN

# of Institutions

627

Shares Held

183M

Call Options Held

1.63M

Put Options Held

1.2M

Black Rock Inc. New York, NY

22.7M
Shares

$1.51 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$1.27 Billion
0.03% of portfolio
Primecap Management CO Pasadena, CA

18.8M
Shares

$1.25 Billion
1.14% of portfolio
Dodge & Cox San Francisco, CA

13.9M
Shares

$928 Million
0.72% of portfolio
Capital Research Global Investors Los Angeles, CA

9.69M
Shares

$646 Million
0.18% of portfolio

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ibm Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Ibm Retirement Fund with notifications on news.

Account